Aytu bioscience Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Aytu bioscience Contact Number

Aytu BioScience Customer Service Phone Number (855) 298

6 hours ago Pissedconsumer.com Show details

Contact Aytu BioScience customer support at toll-free phone number. Call or write an email to resolve Aytu BioScience issues. Visit the company website aytubio.com or live chat for more information.

Category: Phone Number, Customer ServiceShow more

Contact Aytu BioPharma

8 hours ago Aytubio.com Show details

855-298-8246

Aytu BioPharma, Inc. 373 Inverness Parkway, Suite 206 Englewood, CO 80112 USA +1 (855) AYTU BIO (+1 855-298-8246)

Category: Contact SupportShow more

Aytu BioPharma Home Aytu BioScience

Just Now Aytubio.com Show details

855-298-8246

Aytu BioPharma, Inc. 373 Inverness Parkway, Suite 206 Englewood, CO 80112 USA +1 (855) AYTU BIO (+1 855-298-8246)

Category: Home PhoneShow more

Aytu BioScience Crunchbase Company Profile & Funding

5 hours ago Crunchbase.com Show details

(720) 437-6580

Legal Name Aytu BioScience, Inc. Stock Symbol OTCQX:AYTU. Company Type For Profit. Contact Email [email protected] Phone Number 1 (720) 437-6580. Aytu BioScience is a specialty healthcare company concentrating on developing products for redox-modulated conditions with a focus on urological indications and related conditions. Aytu BioScience is

Founder: Josh Disbrow
Location: Englewood, Colorado
Founded: Jul 01, 2007

Category: Contact NumberShow more

David Green Chief Financial Officer at Aytu Bioscience

4 hours ago Wiza.co Show details

View David Green's email address (d*****@aytub***.com) and phone number. David works at Aytu Bioscience, Inc. as Chief Financial Officer. David is based out of San Francisco, California, United States and works in the Pharmaceuticals industry.

Category: Contact NumberShow more

Aytu BioScience, Inc. (AYTU) Company Profile & Overview

6 hours ago Stockanalysis.com Show details

Company profile for Aytu BioScience, Inc. (AYTU) with a description, list of executives, contact details and other key facts. Company profile for Aytu BioScience, Inc. (AYTU) with a description, list of executives, contact details and other key facts. CUSIP Number: 054754106: ISIN Number: US0547548745: Employer ID: 47-0883144: Key

Category: Contact NumberShow more

Aytu BioScience, Inc. Email Format aytubio.com Emails

2 hours ago Rocketreach.co Show details

Aytu BioScience, Inc. uses 4 email formats: 1. first_initial [email protected] (78.8%). Enter a name to find & verify an email >>> we have a process in place the begins with RocketReach and ends with huge contact lists for our sales team..it probably saves Feedtrail about 3 months of work in terms of lead gathering. With the shear number

Category: Contact NumberShow more

BIOLIDICS LIMITED APPOINTMENT OF AYTU BIOSCIENCE, …

6 hours ago Biolidics.com Show details

1 BIOLIDICS LIMITED (Company Registration Number: 200913076M) _____ APPOINTMENT OF AYTU BIOSCIENCE, INC.

Category: Contact NumberShow more

AYTU BIOSCIENCE, INC (Form: 10K, Received: …

9 hours ago Content.edgar-online.com Show details

On October 26, 2017, Gregory A. Gould resigned as the Chief Financial Officer of Aytu BioScience, Inc. Mr. Gould’s resignation became effective on November 15, 2017. We entered into an employment agreement with David A. Green, effective December 18, 2017, to serve as our Chief Financial Officer.

Category: Contact NumberShow more

EarningsCast Aytu BioScience, Inc. Earnings Calls

3 hours ago Earningscast.com Show details

Q3 2020 Aytu BioScience Inc Earnings Call. 05/14/2020 04:30 PM (EDT) AYTU. Act -0.01. Est -0.245.

Category: Contact NumberShow more

Aytu Bioscience, Inc. (AYTU) May Report Negative Earnings

4 hours ago Finance.yahoo.com Show details

So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number. For the last reported quarter, it was expected that Aytu Bioscience, Inc. Would post a …

Category: Contact NumberShow more

Aytu BioPharma Company Profile Office Locations

2 hours ago Craft.co Show details

Aytu BioPharma has 53 employees at their 1 location and $27.63 M in annual revenue in FY 2020. See insights on Aytu BioPharma including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.

Category: Contact NumberShow more

Aytu Bioscience, Inc Sample Contracts Law Insider

2 hours ago Lawinsider.com Show details

Aytu Bioscience, Inc – SECURITIES PURCHASE AGREEMENT. This Securities Purchase Agreement (this “Agreement”) is dated as of March 12, 2020, between Aytu BioScience, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

Category: Contact NumberShow more

Aytu Bioscience Inc. See Full Importer History

8 hours ago Importgenius.com Show details

See their past imports from Rechon Life Science Ab, a supplier based in Germany. Follow future shipping activity from Aytu Bioscience Inc.. Container Number: OOLU6515063 + Get verified contact information. Contact this company. Related Companies.

Category: Contact NumberShow more

Investigating Aytu BioScience, Inc. Monteverde

Just Now Monteverdelaw.com Show details

Contact; Aytu BioScience, Inc. Aytu BioScience, Inc. relating to its purchase agreement with Cerecor Inc. We are investigating its Board of Directors for potential securities laws violations and/or breaches of fiduciary duties in connection with the Purchase Agreement with Cerecor Inc for its pediatric and primary care product lines (the

Category: Contact NumberShow more

AYTU BIOSCIENCE, INC (Form: 8K, Received: 04/24/2020 08

8 hours ago Content.edgar-online.com Show details

The 2020 annual meeting of stockholders for Aytu BioScience, Inc. was held on April 23, 2020. Of the 27,828,312 shares outstanding on the record date for the meeting, a total of 21,331,054 shares were present or represented at the meeting. Number of Votes Cast For Contact

Category: Contact NumberShow more

Aytu Consumer health Better Business Bureau® Profile

4 hours ago Bbb.org Show details

BBB accredited since 2/17/2021. Vitamins and Supplements in Englewood, CO. See BBB rating, reviews, complaints, request a quote & more.

Category: Contact NumberShow more

Aytu BioScience Investigated for Possible Securities Laws

4 hours ago Finance.yahoo.com Show details

If you purchased or acquired shares of Aytu common stock and have questions about your legal rights or possess information relevant to this matter, please contact Block & …

Category: Contact NumberShow more

Suzane Kennedy's email & phone Aytu BioScience, Inc.'s

2 hours ago Rocketreach.co Show details

We had no where to begin. Scouring the web at all hours of the night wasn't gonna cut it. RocketReach has given us a great place to start. Our workflow has solid direction now - we have a process in place the begins with RocketReach and ends with huge contact lists for our sales team..it probably saves Feedtrail about 3 months of work in terms of lead gathering.

Category: Phone NumberShow more

Innovus Pharmaceuticals Crunchbase Company Profile & Funding

3 hours ago Crunchbase.com Show details

858-964-5123

Contact Email [email protected] Phone Number 858-964-5123 Innovus Pharma (INNV) is an emerging pharmaceutical company that develops, in-licenses, acquires, and markets prescription and consumer health products in dermatology, autoimmune, respiratory, and sexual dysfunction diseases with unique packaging and presentation for better patient

Category: Contact NumberShow more

Why Aytu Bioscience (AYTU) rose on Wednesday

7 hours ago Moneymidnight.com Show details

Shares of Aytu Bioscience (AYTU) rose to $8 from $0.88 in Wednesday’s intraday trading session.. According to a recent SEC filing, Aytu BioScience’s Board of Directors approved a 1-for-10 reverse stock split of the Company’s common stock, which will be effective at 8:00 a.m. Eastern Time on Tuesday, December 8, 2020. The Company’s stockholders approved the reverse stock split …

Category: Contact NumberShow more

AYTU Stock Aytu Biopharma, Inc SEC Filings

Just Now Sec.report Show details

Aytu Biopharma, Inc is primarely in the business of pharmaceutical preparations. For financial reporting, their fiscal year ends on June 30th. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Aytu

Category: Contact NumberShow more

SEC FORM D/A

4 hours ago Sec.gov Show details

720-437-6580

Principal Place of Business and Contact Information. Name of Issuer; AYTU BIOSCIENCE, INC: Street Address 1 Street Address 2; 373 Inverness Parkway: Suite 206: City State/Province/Country ZIP/PostalCode Phone Number of Issuer; Englewood: COLORADO: 80112: 720-437-6580: 3. Related Persons. Last Name First Name Middle Name; Disbrow: Joshua: R

Category: Contact NumberShow more

ARMISTICE CAPITAL, LLC SC 13D/A Filing Concerning AYTU on

6 hours ago Whalewisdom.com Show details

The name of the issuer is Aytu Bioscience, Inc., a Delaware corporation (the "Issuer"). The address of the Issuer's principal executive offices is 373 Inverness Parkway, Suite 206, Englewood, Colorado 80112. This Amendment No. 6 to Schedule 13D relates to the Issuer's Common Stock, par value $.0001 per share (the "Shares").

Category: Contact NumberShow more

Contact Us Confirm BioSciences

6 hours ago Confirmbiosciences.com Show details

Contact Us. Are you interested in bringing novel screening solutions to your business, or want to learn more about our offerings? We’d love to hear from you. Drop us a note below and our team of dedicated representatives will follow up with you soon. Name. Email. Phone. Company. Country.

Category: Contact SupportShow more

AYTU 13F Hedge Fund and Asset Management Owners

4 hours ago Whalewisdom.com Show details

373 INVERNESS PARKWAY ENGLEWOOD, CO 80112. Aytu BioScience, Inc. operates as a specialty healthcare company. The Company concentrates on acquiring, developing, and commercializing products focused primarily on sexual disfunction disorders, urological cancer, urinary tract infections, and male infertility.

Category: Contact NumberShow more

This is Why Aytu Bioscience Inc (NASDAQ:AYTU) Stock

7 hours ago Insiderfinancial.com Show details

By Jim Bloom. Written Post on March 11 2020. Aytu Bioscience Inc (NASDAQ:AYTU) is exploding higher even as the broader stock market continues to record steep pullbacks. A 400% plus rally has helped catapult the stock from all-time lows, affirming renewed investor interest after a …

Category: Contact NumberShow more

Patents Assigned to Aytu BioScience, Inc. Justia Patents

5 hours ago Patents.justia.com Show details

The test strip also includes a reference cell. The oxidation-reduction potential of a fluid sample placed in the sample chamber can be read by a readout device interconnected to a test lead that is in electrical contact with the sample chamber, and a reference lead that is in electrical contact

Category: Contact NumberShow more

Is Aytu BioScience (NasdaqCM: AYTU) Building Another Arbor

3 hours ago Prdistribution.com Show details

The global sleep aid market is currently estimated at almost $50 billion in annual revenue, and that number is expected to reach nearly $80 billion in 2022. SUDA Pharmaceuticals is a drug delivery company focused on oro-mucosal administration and is headquartered in …

Category: Contact NumberShow more

Aytu BioPharma Number of Employees 20082021 AYTU

1 hours ago Macrotrends.net Show details

Aytu BioPharma number of employees from 2008 to 2021. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Aytu BioScience, Inc. is a healthcare company which focused on commercialization of novel products in the field of urology.

Category: Contact NumberShow more

Aytu BioScience Announces Emergency Use Authorization of

8 hours ago Biospace.com Show details

Aytu BioScience announced a U.S. distribution agreement to distribute the Zhejiang Orient Gene rapid test on March 10, 2020. The COVID-19 IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma) is a qualitative test for the detection and differentiation of IgM and IgG antibodies against SARS-CoV-2 in whole blood, plasma (Li+-heparin, K2-EDTA and

Category: Contact NumberShow more

Aytu BioPharma Inc. (Nasdaq: AYTU) :: LD Micro

6 hours ago Ldmicro.com Show details

Aytu BioPharma to Report Fourth Quarter and Full Year Fiscal 2021 Results and Provide Business Update on September 27, 2021. 09/09/2021 08:00 AM EDT. ACCESSWIRE. Aytu BioPharma Announces Formation of New Scientific Advisory Board to Support Development of AR101 for Vascular Ehlers-Danlos Syndrome. 09/07/2021 08:00 AM EDT.

Category: Contact NumberShow more

Aytu BioPharma, Inc. (AYTUP) Insider Activity Nasdaq

8 hours ago Nasdaq.com Show details

Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is exempt of filing insider holdings

Category: Contact NumberShow more

AYTU News Today (Aytu Biopharma) MarketBeat

1 hours ago Marketbeat.com Show details

finanznachrichten.de - February 11 at 6:20 PM. Aytu BioScience Announces Record Fiscal Q2 2021 Net Revenue of $15.1 Million, an Increase of 377% Year-Over-Year. finance.yahoo.com - February 11 at 6:20 PM. Aytu BioScience to Report Second Fiscal 2021 Results and Provide Business Update on Thursday, February 11, 2021.

Category: Contact NumberShow more

BIOLIDICS LIMITED RESPONSE TO SGX QUERIES …

7 hours ago Biolidics.com Show details

biolidics limited (company registration number: 200913076m) response to sgx queries – announcements in relation to appointment of aytu bioscience, inc. as exclusive distributor

Category: Contact NumberShow more

Aytu BioScience (AYTU) Targets Combined $7 Billion Market

3 hours ago Youtube.com Show details

Aytu BioScience (NasdaqCM: AYTU) may be one of the most compelling small-cap biotech investment opportunities. Trading at less than cash value, AYTU has thre

Category: Contact NumberShow more

Aytu_ex991 SEC

1 hours ago Sec.gov Show details

ENGLEWOOD, CO / ACCESSWIRE / April 20, 2020 / Aytu BioScience, Inc. (NASDAQ: AYTU) (the “Company”), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs announced today that it has signed an exclusive worldwide license from Cedars-Sinai to develop and commercialize the Healight Platform Technology (“Healight”).

Category: Contact NumberShow more

AYTU BIOPHARMA, INC. : Shareholders Board Members Managers

9 hours ago Marketscreener.com Show details

Aytu Biopharma, Inc., formerly Aytu BioScience, Inc., is a specialty pharmaceutical company. The Company markets a portfolio of prescription products addressing primary care and pediatric markets. The Company's primary prescription products treat attention deficit hyperactivity disorder (ADHD) and other common pediatric conditions.

Category: Contact NumberShow more

UV light treatment to fight coronavirus was already being

1 hours ago The-sun.com Show details

Aytu Bioscience is developing a potential coronavirus therapy based on UV light Credit: Aytu BioScience The announcement was made on April 20, a few days before Trump's now-infamous press briefing where he suggested treating COVID-19 with UV light and injecting bleach.

Category: Contact NumberShow more

Adam Dmitriev Specialty Sales Representative Optinose

Just Now Linkedin.com Show details

Jan 2008 - 20113 years. Responsible for increasing sales and market share by promoting a number of products to a variety of physicians. Proven ability to build relationships with physicians and

Title: Multiple award winning senior …
Location: San Antonio, Texas, United States
1. 500+ connections

Category: Contact NumberShow more

Aytu BioScience Announces Definitive Agreement to Acquire

8 hours ago Stockdaymedia.com Show details

Aytu BioScience Announces Definitive Agreement to Acquire Innovus Pharmaceuticals. September 12, 2019. September 12, 2019. Stock Day Media 913 Views. Acquisition Gives Aytu Timely Entry into Growing Consumer Healthcare Market with a Portfolio of Over 30 Products that Generated $24M of Revenue During Past Four Quarters.

Category: Contact NumberShow more

Aytu BioScience : Prospectus MarketScreener

2 hours ago Marketscreener.com Show details

On June 8, 2015, we (i) reincorporated as a domestic Delaware corporation under Delaware General Corporate Law and changed our name from Rosewind Corporation to Aytu BioScience, Inc., and (ii) effected a reverse stock split in which each Common Stock holder received one share of Common Stock for each 12.174 shares outstanding.

Category: Contact NumberShow more

What is Aytu Biopharma Valuation Today? AYTU Macroaxis

5 hours ago Macroaxis.com Show details

Aytu Biopharma reported Enterprise Value of 139.3 Million in 2020. Tangible Asset Value is likely to gain to about 94.7 M in 2021, whereas Free Cash Flow is likely to drop (26.2 M) in 2021. Aytu Biopharma shows a prevailing Real Value of $6.56 per share. The current price of the firm is $3.08.

Category: Contact NumberShow more

Brandon Conner Senior Sales Specialist & Field Sales

1 hours ago Linkedin.com Show details

Territory Manager & Regional Trainer. Aytu BioScience. Nov 2019 - Present1 year 9 months. Englewood, Colorado, United States. Aytu BioScience acquired Cerecor Sales Force.

Title: Senior Sales Specialist & Field …
Location: New York City Metropolitan
Connections: 332

Category: Contact NumberShow more

Working at Aytu BioScience: Employee Reviews Indeed.com

Just Now Indeed.com Show details

Reviews from Aytu BioScience employees about Aytu BioScience culture, salaries, benefits, work-life balance, management, job security, and more.

Rating: 3.6/5(5)

Category: Contact NumberShow more

Acerus And Aytu Bioscience To CoPromote NATESTO® In The

2 hours ago Biospace.com Show details

TORONTO, July 30, 2019 /PRNewswire/ -- Acerus Pharmaceuticals Corporation (TSX:ASP, OTCQB: ASPCF) today announced that it will be taking an expanded role in the commercialization of NATESTO ® in the U.S. The company has entered into an amended and restated licensing agreement with Aytu BioScience, Inc. (NASDAQ: AYTU), which will, upon closing

Category: Contact NumberShow more

Aytu Biopharma Target Price Estimate for November 2021 AYTU

3 hours ago Macroaxis.com Show details

Aytu Biopharma Target Price Projection. Aytu Biopharma's current and average target prices are 3.29 and 17.50, respectively. The current price of Aytu Biopharma is the price at which Aytu Biopharma is currently trading. On the other hand, Aytu Biopharma's target price is what analysts think the stock is worth or could sell for in the future.

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Brand New Updated

Frequently Asked Questions

What kind of company is aytu biosciences?

Aytu BioScience is a specialty pharmaceutical company focused on delivering novel therapeutics to improve the health of patients. Better health means better living.

Where is aytu biopharma located in englewood colorado?

Aytu BioPharma, Inc. 373 Inverness Parkway, Suite 206 Englewood, CO 80112 USA +1 (855) AYTU BIO (+1 855-298-8246)

When does aytu bioscience reverse stock split take place?

The common shares will trade under a new CUSIP number, 054754874, effective December 9, 2020, and continue to trade under the symbol “AYTU.” All stock options and warrants of the Company outstanding immediately prior to the reverse stock split have been proportionally adjusted.

Who is investigating aytu bioscience for securities fraud?

BOSTON, April 17, 2020 (GLOBE NEWSWIRE) -- Block & Leviton LLP ( www.blockesq.com ), a national securities litigation firm, is investigating Aytu BioScience, Inc. ( AYTU) and certain of its officers for potential securities fraud. Investors who purchased Aytu shares should contact Block & Leviton for a free case evaluation.

Brand New Updated

Popular Brands

Amazon
Abbvie
Aia
Asml
Att
Amgen
Apple
Adobe
Aptar
Acc
Adidas
Aak
Aes